{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T23:24:15Z","timestamp":1783553055321,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010857","name":"Jiangxi Province Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.neuropharm.2021.108488","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T17:21:39Z","timestamp":1612632099000},"page":"108488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Oxytocin mediates neuroprotection against hypoxic-ischemic injury in hippocampal CA1 neuron of neonatal rats"],"prefix":"10.1016","volume":"187","author":[{"given":"Zhihong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changning","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108488_bib1","doi-asserted-by":"crossref","first-page":"4864107","DOI":"10.1155\/2018\/4864107","article-title":"Molecular mechanisms of oxytocin signaling at the synaptic connection","volume":"2018","author":"Bakos","year":"2018","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2021.108488_bib2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrn920","article-title":"Excitatory actions of gaba during development: the nature of the nurture","volume":"3","author":"Ben-Ari","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108488_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1073858412438697","article-title":"The GABA excitatory\/inhibitory shift in brain maturation and neurological disorders","volume":"18","author":"Ben-Ari","year":"2012","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2021.108488_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1744-8069-4-19","article-title":"Oxytocin-induced antinociception in the spinal cord is mediated by a subpopulation of glutamatergic neurons in lamina I-II which amplify GABAergic inhibition","volume":"4","author":"Breton","year":"2008","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2021.108488_bib5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/ALN.0b013e318266c62d","article-title":"Roles of aldosterone and oxytocin in abnormalities caused by sevoflurane anesthesia in neonatal rats","volume":"117","author":"Cao","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2021.108488_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neulet.2010.04.024","article-title":"Oxytocin is neuroprotective against oxygen-glucose deprivation and reoxygenation in immature hippocampal cultures","volume":"477","author":"Ceanga","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2021.108488_bib7","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1523\/JNEUROSCI.5139-11.2012","article-title":"Traumatic alterations in GABA signaling disrupt hippocampal network activity in the developing brain","volume":"32","author":"Dzhala","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108488_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuroscience.2019.04.006","article-title":"Systemic oxytocin administration alters mesolimbic dopamine release in mice","volume":"408","author":"Estes","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108488_bib9","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1471-4159.2006.04425.x","article-title":"Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus","volume":"101","author":"Frenguelli","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108488_bib10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/physrev.2001.81.2.629","article-title":"The oxytocin receptor system: structure, function, and regulation","volume":"81","author":"Gimpl","year":"2001","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2021.108488_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41380-020-0802-9","article-title":"Brain oxytocin: how puzzle stones from animal studies translate into psychiatry","volume":"26","author":"Grinevich","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108488_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/brain\/awv360","article-title":"Enhanced phasic GABA inhibition during the repair phase of stroke: a novel therapeutic target","volume":"139","author":"Hiu","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2021.108488_bib13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1152\/jn.00609.2013","article-title":"Synaptic modulation and inward current produced by oxytocin in substantia gelatinosa neurons of adult rat spinal cord slices","volume":"111","author":"Jiang","year":"2014","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2021.108488_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.1991.tb04893.x","article-title":"Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduces loss of hippocampal CA1 pyramidal cells","volume":"84","author":"Johansen","year":"1991","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuropharm.2021.108488_bib15","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1161\/STROKEAHA.111.628008","article-title":"Oxytocin mediates social neuroprotection after cerebral ischemia","volume":"42","author":"Karelina","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2021.108488_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuroscience.2016.10.067","article-title":"Differential spread of anoxic depolarization contributes to the pattern of neuronal injury after oxygen and glucose deprivation (Ogd) in the substantia Nigra in rat brain slices","volume":"340","author":"Karunasinghe","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108488_bib17","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1038\/ncomms8750","article-title":"GABA depolarizes immature neurons and inhibits network activity in the neonatal neocortex in vivo","volume":"6","author":"Kirmse","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108488_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41386-018-0171-0","article-title":"Oxytocin attenuates phencyclidine hyperactivity and increases social interaction and nucleus accumben dopamine release in rats","volume":"44","author":"Kohli","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108488_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1254\/jphs.SC0070119","article-title":"A low-cost method for brain slice cultures","volume":"104","author":"Koyama","year":"2007","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108488_bib20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/pr.2017.266","article-title":"The effects of adding prophylactic phenobarbital to therapeutic hypothermia in the term-equivalent hypoxic-ischemic rat","volume":"83","author":"Krishna","year":"2018","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2021.108488_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.celrep.2016.03.013","article-title":"The timing of the excitatory-to-inhibitory GABA switch is regulated by the oxytocin receptor via KCC2","volume":"15","author":"Leonzino","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2021.108488_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41467-017-00675-5","article-title":"Oxytocin stimulates hippocampal neurogenesis via oxytocin receptor expressed in CA3 pyramidal neurons","volume":"8","author":"Lin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108488_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(14)61698-6","article-title":"Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis","volume":"385","author":"Liu","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2021.108488_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuropharm.2015.03.001","article-title":"Minocycline inhibits hyperpolarization-activated currents in rat substantia gelatinosa neurons","volume":"95","author":"Liu","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108488_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/glia.23546","article-title":"Oxytocin receptor agonist reduces perinatal brain damage by targeting microglia","volume":"67","author":"Mairesse","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2021.108488_bib26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fncel.2019.00178","article-title":"Oxytocin increases phasic and tonic GABAergic transmission in CA1 region of mouse Hippocampus","volume":"13","author":"Maniezzi","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108488_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115273","article-title":"The selective antagonism of P2X7 and P2Y1 receptors prevents synaptic failure and affects cell proliferation induced by oxygen and glucose deprivation in rat dentate gyrus","volume":"9","author":"Maraula","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2021.108488_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1152\/jn.00384.2002","article-title":"GABA-mediated inhibition of glutamate release during ischemia in substantia gelatinosa of the adult rat","volume":"89","author":"Matsumoto","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2021.108488_bib29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn3044","article-title":"Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine","volume":"12","author":"Meyer-Lindenberg","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108488_bib30","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1523\/JNEUROSCI.2409-15.2016","article-title":"A distributed network for social cognition enriched for oxytocin receptors","volume":"36","author":"Mitre","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108488_bib31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.mcn.2015.08.013","article-title":"Oxytocin excites nucleus accumbens shell neurons in vivo","volume":"68","author":"Moaddab","year":"2015","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108488_bib32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(11)61577-8","article-title":"Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review","volume":"379","author":"Mwaniki","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2021.108488_bib33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nature12330","article-title":"Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons","volume":"500","author":"Owen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108488_bib34","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3390\/jcm9051534","article-title":"Hypothalamic neuropeptide brain protection: focus on oxytocin","volume":"9","author":"Panaro","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuropharm.2021.108488_bib35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuroscience.2017.06.046","article-title":"Contribution of presynaptic HCN channels to excitatory inputs of spinal substantia gelatinosa neurons","volume":"358","author":"Peng","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108488_bib36","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1038\/s41467-017-02173-0","article-title":"Hippocampal oxytocin receptors are necessary for discrimination of social stimuli","volume":"8","author":"Raam","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108488_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22466","article-title":"Transient oxytocin signaling primes the development and function of excitatory hippocampal neurons","volume":"6","author":"Ripamonti","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2021.108488_bib38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/35002090","article-title":"Glutamate release in severe brain ischaemia is mainly by reversed uptake","volume":"403","author":"Rossi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108488_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","article-title":"Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species","volume":"106\u2013107","author":"Semple","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108488_bib40","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa1112066","article-title":"Childhood outcomes after hypothermia for neonatal encephalopathy","volume":"366","author":"Shankaran","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2021.108488_bib41","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1460-9568.2012.07993.x","article-title":"Hippocampal CA3 and CA2 have distinct bilateral innervation patterns to CA1 in rodents","volume":"35","author":"Shinohara","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108488_bib42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/13895260500327979","article-title":"A randomized controlled trial of phenobarbital in neonates with hypoxic ischemic encephalopathy","volume":"18","author":"Singh","year":"2005","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.neuropharm.2021.108488_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0883073812470734","article-title":"Pharmacological treatment of neonatal seizures: a systematic review","volume":"28","author":"Slaughter","year":"2013","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuropharm.2021.108488_bib44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41593-018-0118-0","article-title":"CA1 pyramidal cell diversity enabling parallel information processing in the hippocampus","volume":"21","author":"Soltesz","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108488_bib45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuron.2012.09.025","article-title":"Neuromodulation by oxytocin and vasopressin","volume":"76","author":"Stoop","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108488_bib46","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1152\/jn.1997.78.2.891","article-title":"Mechanisms underlying the rapid depolarization produced by deprivation of oxygen and glucose in rat hippocampal CA1 neurons in vitro","volume":"78","author":"Tanaka","year":"1997","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2021.108488_bib47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.neuron.2018.09.008","article-title":"Oxytocin transforms firing mode of CA2 hippocampal neurons","volume":"100","author":"Tirko","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108488_bib48","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1126\/science.1133212","article-title":"Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery","volume":"314","author":"Tyzio","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108488_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2013.00020","article-title":"Excitatory actions of GABA in the intact neonatal rodent hippocampus in vitro","volume":"7","author":"Valeeva","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108488_bib50","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bph.12454","article-title":"Novel analogues of chlormethiazole are neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABA(A) receptor potentiation","volume":"171","author":"Vandevrede","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108488_bib51","doi-asserted-by":"crossref","first-page":"41 e41","DOI":"10.1016\/j.ajog.2014.03.033","article-title":"Perinatal risk factors for severe injury in neonates treated with whole-body hypothermia for encephalopathy","volume":"211","author":"Wayock","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.neuropharm.2021.108488_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/aps.2012.95","article-title":"Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction","volume":"34","author":"Weilinger","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2021.108488_bib53","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1152\/jn.00701.2011","article-title":"Examining protection from anoxic depolarization by the drugs dibucaine and carbetapentane using whole cell recording from CA1 neurons","volume":"107","author":"White","year":"2012","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2021.108488_bib54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuroscience.2015.09.046","article-title":"Increased excitability and excitatory synaptic transmission during in vitro ischemia in the neonatal mouse hippocampus","volume":"310","author":"Zanelli","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108488_bib55","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1046\/j.1460-9568.2000.00290.x","article-title":"Oxytocin receptor agonists enhance inhibitory synaptic transmission in the rat hippocampus by activating interneurons in stratum pyramidale","volume":"12","author":"Zaninetti","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108488_bib56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2008.03.006","article-title":"Resveratrol attenuates early pyramidal neuron excitability impairment and death in acute rat hippocampal slices caused by oxygen-glucose deprivation","volume":"212","author":"Zhang","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108488_bib57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neulet.2012.02.067","article-title":"Functional response of hippocampal CA1 pyramidal cells to neonatal hypoxic-ischemic brain damage","volume":"516","author":"Zhao","year":"2012","journal-title":"Neurosci. Lett."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:08:58Z","timestamp":1758438538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":57,"alternative-id":["S0028390821000423"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108488","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxytocin mediates neuroprotection against hypoxic-ischemic injury in hippocampal CA1 neuron of neonatal rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108488"}}